The effect of hyperglycaemia on haemostasis testing - A volunteer study

Anaesthesia

Volumn 70, Issue 5, 2015, Pages 549-554

  Lippi, G ^a   Buonocore, R ^a   Musa, R ^a   Ippolito, L ^a   Picanza, A ^a   Favaloro, E J ^b  

^a ACADEMIC HOSPITAL OF PARMA   (Italy)

^b WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; GLUCOSE; GLUCOSE BLOOD LEVEL;

ARTICLE; BLOOD CONTAMINATION; BLOOD SAMPLING; CLINICAL ARTICLE; CONTAMINATION; CONTROLLED STUDY; HEMATOLOGICAL PARAMETERS; HEMOSTASIS; HUMAN; HYPERGLYCEMIA; LABORATORY TEST; NORMAL HUMAN; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; VENOUS BLOOD; ANALYSIS; BLOOD; BLOOD EXAMINATION; GLUCOSE BLOOD LEVEL; REFERENCE VALUE; REPRODUCIBILITY;

BLOOD GLUCOSE; FIBRINOGEN; HEALTHY VOLUNTEERS; HEMATOLOGIC TESTS; HEMOSTASIS; HUMANS; HYPERGLYCEMIA; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS;

EID: 84926622098     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/anae.12990     Document Type: Article

References (27)

1. Lippi G, Becan-McBride K, Behúlová D, et al. Preanalytical quality improvement: in quality we trust. Clinical Chemistry and Laboratory Medicine 2013; 51: 229-41.
2. O'Hare D, Chilvers RJ,. Arterial blood sampling practices in intensive care units in England and Wales. Anaesthesia 2001; 56: 568-71.
3. Leslie RA, Gouldson S, Habib N, et al. Management of arterial lines and blood sampling in intensive care: a threat to patient safety. Anaesthesia 2013; 68: 1114-9.
4. Gupta KJ, Cook TM,. Accidental hypoglycaemia caused by an arterial flush drug error: a case report and contributory causes analysis. Anaesthesia 2013; 68: 1179-87.
5. Thirugnanam M, French J,. Accidental hypoglycaemia caused by an arterial flush drug error. Anaesthesia 2014; 69: 524-5.
6. Lippi G, Avanzini R, Sandei F, Aloe R, Cervellin G,. Blood sample contamination by glucose-containing solutions: effects and identification. British Journal of Biomedical Sciences 2013; 70: 180-3.
7. Clinical Laboratory Standards Institute. Procedures for Collection of Diagnostic Blood Specimens by Venipuncture; Approved Guideline-6th Ed. CLSI document H3-A6. Wayne, PA: Clinical and Laboratory Standards Institute, 2007.
8. Read DC, Viera H, Arkin C,. Effect of drawing blood specimens proximal to an in-place but discontinued intravenous solution. Can blood be drawn above the site of a shut-off i.v.? American Journal of Clinical Pathology 1988; 90: 702-6.
9. Association of Anaesthetists of Great Britain and Ireland. Arterial line blood sampling: preventing hypoglycaemic brain injury 2014. Anaesthesia 2014; 69: 380-5.
10. Adcock DM, Hoefner DM, Kottke-Marchant K, Marlar RA, Szamosi DI, Warunek DJ,. Collection, Transport, and Processing of Blood Specimens for Testing Plasma-based Coagulation Assays and Molecular Hemostasis Assays: Approved Guideline-fifth Edition. CLSI document H21-A5. Wayne, PA: Clinical Laboratory Standards Institute, 2008.
11. Milos M, Herak D, Kuric L, Horvat I, Zadro R,. Evaluation and performance characteristics of the coagulation system: ACL TOP analyzer-HemosIL reagents. International Journal of Laboratory Hematology 2009; 31: 26-35.
12. Ricos C, Alvarez V, Cava F, Garcia-Lario JV, et al. Current databases on biologic variation: pros, cons and progress. Scandinavian Journal of Clinical and Laboratory Investigation 1999; 59: 491-500.
13. Plebani M, Favaloro EJ, Lippi G,. Patient safety and quality in laboratory and hemostasis testing: a renewed loop? Seminars in Thrombosis and Hemostasis 2012; 38: 553-8.
14. Vander AJ, Sherman JH, Luciano DS,. Human Physiology-The Mechanisms of Body Function, 8th edn. New York: McGraw Hill, 2001: 115-41. ISBN: 0071183825.
15. Gallagher PG,. Disorders of red cell volume regulation. Current Opinion in Hematology 2013; 20: 201-7.
16. Lippi G, Franchini M, Targher G, et al. Epidemiological association between fasting plasma glucose and shortened APTT. Clinical Biochemistry 2009; 42: 118-20.
17. Zhao Y, Zhang J, Zhang J, Wu J,. Diabetes mellitus is associated with shortened activated partial thromboplastin time and increased fibrinogen values. PLoS One 2011; 6: e16470.
18. Sapkota B, Shrestha SK, Poudel S,. Association of activated partial thromboplastin time and fibrinogen level in patients with type II diabetes mellitus. BMC Research Notes 2013; 6: 485.
19. Lippi G, Salvagno GL, Ippolito L, Franchini M, Favaloro EJ,. Shortened activated partial thromboplastin time: causes and management. Blood Coagulation and Fibrinolysis 2010; 21: 459-63.
20. Girolami A, Vidal J, Salagh M, et al. The old and the new in prekallikrein deficiency: historical context and a family from Argentina with PK deficiency due to a new mutation (Arg541Gln) in exon 14 associated with a common polymorphysm (Asn124Ser) in exon 5. Seminars in Thrombosis and Hemostasis 2014; 40: 592-9.
21. Liu J, Gao BB, Clermont AC, et al. Hyperglycemia-induced cerebral hematoma expansion is mediated by plasma kallikrein. Nature Medicine 2011; 17: 206-10.
22. Patrassi GM, Vettor R, Padovan D, Girolami A,. Contact phase of blood coagulation in diabetes mellitus. European Journal of Clinical Investigation 1982; 12: 307-11.
23. Federspil G, Vettor R, De Palo E, Padovan D, Sicolo N, Scandellari C,. Plasma kallikrein activity in human diabetes mellitus. Metabolism 1983; 32: 540-2.
24. Feener EP, Zhou Q, Fickweiler W,. Role of plasma kallikrein in diabetes and metabolism. Thrombosis and Haemostasis 2013; 110: 434-41.
25. de Maat S, de Groot PG, Maas C,. Contact system activation on endothelial cells. Seminars in Thrombosis and Hemostasis 2014; 40: 887-94.
26. ®). Anaesthesia 2014; 69: 883-90.
27. Theusinger OM, Nürnberg J, Asmis LM, Seifert B, Spahn DR,. Rotation thromboelastometry (ROTEM) stability and reproducibility over time. European Journal of Cardiothoracic Surgery 2010; 37: 677-83.